HELIOS SOLAR AG: HELIOS SOLAR AG receives admission decision of Frankfurt Stock Exchange (Frankfurter Wertpapierbörse)

HELIOS SOLAR AG (ISIN: DE000A42D2N5, WKN: A42D2N, ticker symbol: HE8) herewith announces that, today, it has received the admission decision from the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse) to the applied-for admission of its shares to trading on the regulated market (General Standard).
The first day of listing of the shares (Notierungsaufnahme) in the regulated market (General Standard), and therefore the first day of trading, is scheduled for 28 July 2026.

Website: www.heliossolarag.com
Contact
Maximilian Fischer, Head of Investor Relations, email: max@heliospv.net
Manuel Taverne, Co-Head of Investor Relations, email: m.taverne@max-em.de
Company Data
HELIOS SOLAR AG, business address: Marienplatz 2, 80331 Munich, Germany; registered office: Frankfurt am Main; commercial register: Local Court (Amtsgericht) Frankfurt am Main, HRB 116214; LEI: 894500Q0LUCCFE8R5J14; ISIN: DE000A42D2N5; WKN: A42D2N; ticker symbol: HE8. Important Notices This announcement constitutes an advertisement within the meaning of Regulation (EU) 2017/1129 as amended (the “Prospectus Regulation”). This announcement may not be published, distributed or transmitted, directly or indirectly, within or into the United States of America, Japan, Canada, New Zealand, Australia or any jurisdiction in which distribution or publication would be unlawful.
This announcement does not constitute an offer to purchase or subscribe for securities (the “Securities”) of HELIOS SOLAR AG (the “Company” or “HELIOS”) nor does it constitute a solicitation to make such an offer. In particular, this announcement does not constitute an offer to purchase securities or a solicitation to make an offer to purchase securities in the United States of America, Japan, Canada, New Zealand, Australia or other jurisdictions in which such an offer would be unlawful.
The Securities of the Company may only be sold or offered for purchase in the United States of America following prior registration or, without prior registration, only pursuant to an exemption from the registration requirements under the provisions of the U.S. Securities Act of 1933, as amended (the “Securities Act”). There will be no public offering of the Securities referred to in this announcement in the United States of America. The Securities of the Company have not been and will not be registered under the Securities Act.
The Securities referred to in this announcement may not be sold or offered for purchase in Japan, Canada, New Zealand or Australia, or to or for the account of persons resident or domiciled in Japan, Canada, New Zealand or Australia, subject to certain exceptions.
In the United Kingdom, this announcement is only being distributed to, and is only directed at, persons who are “qualified investors” within the meaning of Article 2(e) of the Public Offers and Admissions to Trading Regulations 2024 (POATRs) and who are also (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”), or (ii) persons falling within Article 49(2)(a) to (d) of the Order (including “high net worth companies” and “unincorporated associations”), or (iii) persons to whom this announcement may otherwise lawfully be distributed (all such persons together being “relevant persons”). This announcement is directed only at relevant persons, and persons who are not relevant persons must not act or rely on this announcement.
The offering and the admission to the regulated market of the Frankfurt Stock Exchange (General Standard) are made exclusively on the basis of a published securities prospectus dated 2 June 2026 (the “Prospectus”) and a first supplement to the Prospectus dated 26 June 2026 (the “Supplement”), each approved by the German Federal Financial Supervisory Authority (“BaFin”). Any investment decision regarding the Securities of the Company should only be made on the basis of the Prospectus and the Supplement. The Prospectus and the Supplement are available free of charge on the Company’s website (https://www.heliossolarag.com/ under the category “IPO”).
The approval of the Prospectus and the Supplement by BaFin must not be understood as an endorsement of the issuer or the quality of the Securities. Investors should note that BaFin has reviewed the Prospectus and the Supplement only with regard to their completeness, comprehensibility and coherence. Investors should read the Prospectus, including the Supplement, before making an investment decision in order to fully understand the potential risks and opportunities associated with the decision to invest in the shares. An investment in shares involves numerous risks, including the total loss of the invested capital; these risks are described in the first chapter “Risk Factors” of the Prospectus.
The acquisition of investments to which this announcement relates may expose an investor to a significant risk of losing the entire invested amount. Persons considering such investments should consult an authorised person specialising in advising on such investments. This announcement does not constitute a recommendation regarding the offering. The value of shares may decrease as well as increase. Potential investors should consult a professional adviser to assess the suitability of the offering for the person concerned.
End of Announcement